FedSift

SolicitationsDEPT OF DEFENSENAICS 112990

BALB/cJ and C57BL/6J Mice to Support Different Infection Models

DEPT OF DEFENSE · Solicitation N32398NOI · NAICS 112990 · No Set aside used · Closed

Solicitation details

Solicitation numberN32398NOI
Notice IDc4d3db652c6442ce9224d9c73610b2d6
AgencyDEPT OF DEFENSE
Contracting officeDEPT OF DEFENSE
NAICS code112990
Product / service code (PSC)8820
Set-asideNo Set aside used
Notice typeSpecial Notice
Posted12 June 2026
Response deadline19 June 2026 (closed)
Place of performanceSilver Spring, MD, USA

Description

Description: The Combat Wound Infections Division (CWID) at Naval Medical Research Command (NMRC), intends to award a Blanket Purchase Agreement (BPA) to Charles River Laboratories (CRL) and The Jackson Laboratory (JAX) under the authority of FAR 13.106-1(b)(1), Soliciting from a Single Source for purchases not exceeding the Simplified Acquisition Threshold (SAT).The Naval Medical Research Command (NMRC) requires a continuous, flexible supply of up to 5,160 specific-pathogen-free (SPF) laboratory research mice. The requirement consists of female BALB/cJ and C57BL/6J strains, aged 49 56 days, and weighing 12 16 grams. The vendor must guarantee that all models are free from infectious diseases and have not received any prior systemic or topical antimicrobials. Delivery is required on a indefinite-delivery basis to support approximately forty-three (43) in vivo experiments scheduled between August 2026 and August 2027. Because CRL and JAX are approved by Walter Reed Army Institute of Research and planned studies are continuations of ongoing research, study baselines and control determinations have already been established using CRL BALB/cJ and JAX C57BL/6J mice, it is critical to ensure the animals are procured from these exact sources. Sourcing from alternative breeders would introduce unacceptable phenotypic and genotypic variation into the upcoming studies, which would invalidate historical data and jeopardize the integrity of the research. This notice of intent is not a request for competitive proposals. However, any firm that believes it can meet this requirement without introducing the aforementioned phenotypic/genotypic variation to the established baselines may submit a written Capability Statement. Responses must include: Evidence of the ability to provide the exact genetic strains (BALB/cJ C57BL/6J). Evidence that they have been approved by Walter Reed Army Institute of Research. Confirmation of the ability to meet the SPF and antimicrobial-free guarantees. Responses must be submitted to the Contracting Officer at priscilla.v.harrison.civ@health.mil no later than June 19, 2026. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Other open solicitations in NAICS 112990

All NAICS 112990 solicitations →

More from DEPT OF DEFENSE

All DEPT OF DEFENSE solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.